Intra-Cellular Therapies
ITCI
#1745
Rank
ยฃ7.49 B
Marketcap
ยฃ70.68
Share price
0.86%
Change (1 day)
61.61%
Change (1 year)

Intra-Cellular Therapies (ITCI) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : ยฃ0.13 Billion

According to Intra-Cellular Therapies's latest financial reports the company's total liabilities are ยฃ0.13 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Intra-Cellular Therapies - Total liabilities on balance sheet (from 2013 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31ยฃ0.10 B31.67%
2022-12-31ยฃ81.59 M52.9%
2021-12-31ยฃ53.36 M20.32%
2020-12-31ยฃ44.35 M3.52%
2019-12-31ยฃ42.84 M37.71%
2018-12-31ยฃ31.11 M146.62%
2017-12-31ยฃ12.61 M16.16%
2016-12-31ยฃ10.86 M104.75%
2015-12-31ยฃ5.3 M-21.77%
2014-12-31ยฃ6.78 M63.67%
2013-12-31ยฃ4.14 M135.82%
2013-03-31ยฃ0.01 M
2012-12-31ยฃ1.75 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ยฃ2.32 M-98.33%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ39.57 M-71.55%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.20 B 46.77%๐Ÿ‡บ๐Ÿ‡ธ USA